한글목차

세계의 바이러스 제거 시장은 2024년 7억 7,334만 달러에서 2030년까지 12억 6,323만 달러에 이르고, CAGR 8.52%를 보일 것으로 예측됩니다.

세계 바이러스 제거 시장은 치료용 단백질, 백신, 첨단 치료법을 포함한 바이오의약품 제품의 바이러스 안전성 확보를 위한 전문 제품 및 서비스로 구성됩니다. 제조 공정에서 잠재적인 바이러스 오염 물질을 감지, 제거, 비활성화함으로써 이를 실현합니다. 시장 확대의 주요 요인은 복잡한 생물학적 제제에 대한 전 세계적인 수요 증가와 제품 순도와 환자 안전을 보장하기 위해 전 세계 보건 당국의 규제 요건이 강화되고 있기 때문입니다.

주요 시장 성장 촉진요인

주요 시장 과제

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 바이러스 제거 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 용도별(재조합 단백질, 혈액, 백신, 기타)
  • 방법별(바이러스 제거법, 바이러스 불활성화법, 바이러스 감지법)
  • 최종사용자별(제약 기업 및 바이오테크놀러지 기업, CRO, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 바이러스 제거 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 바이러스 제거 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 바이러스 제거 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 바이러스 제거 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 남아프리카공화국

제10장 남미의 바이러스 제거 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병(M&A)
• 제품 출시
• 최근 동향

제13장 세계의 바이러스 제거 시장 : SWOT 분석

제14장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Charles River Laboratories International, Inc.
• Wuxi Biologics Inc
• Eurofins Scientific SE
• Sartorius AG
• Texcell, Inc.
• Biosafety Testing Services, Inc.
• Avance Biosciences Laboratories Inc.

제16장 전략적 제안

제17장 회사 소개 및 면책조항

영문목차

The Global Viral Clearance Market will grow from USD 773.34 Million in 2024 to USD 1263.23 Million by 2030 at a 8.52% CAGR. The global viral clearance market comprises specialized products and services designed to ensure the viral safety of biopharmaceutical products, including therapeutic proteins, vaccines, and advanced therapies, by detecting, removing, or inactivating potential viral contaminants during manufacturing. Market expansion is primarily driven by the escalating global demand for complex biologics and the increasingly stringent regulatory requirements imposed by health authorities worldwide to ensure product purity and patient safety.

Key Market Drivers

The global viral clearance market is significantly driven by the expanding biopharmaceutical and biologics pipeline, which continually introduces a greater volume and diversity of products necessitating stringent viral safety assurance. As pharmaceutical companies intensify research and development efforts, particularly in advanced therapies, the demand for robust viral clearance solutions escalates across all manufacturing stages, from cell line development to final product formulation. The inherent complexity of novel biologics, including cell and gene therapies, mandates sophisticated viral clearance strategies to meet evolving product specifications and ensure patient safety. According to J.P. Morgan, in December 2024, their '2024 Biopharma Industry Insights: Investment Trends, M&A Activity, and Market Dynamics' report indicated that biologics investment for seed and series A rounds reached $3.5 billion, underscoring the substantial financial commitment fueling this pipeline expansion and, consequently, the demand for viral clearance technologies.

Key Market Challenges

A significant challenge impeding the expansion of the global viral clearance market is the substantial investment and specialized technical expertise necessary for developing and validating effective viral clearance strategies, especially for new and varied biopharmaceutical products. This requirement places a considerable financial burden on manufacturers, particularly for smaller and emerging companies, limiting their capacity to adopt or innovate in viral clearance technologies. The complexity associated with ensuring viral safety for novel modalities, such as gene therapies or advanced protein therapeutics, demands extensive research and development resources, along with highly skilled personnel to navigate intricate regulatory pathways and perform rigorous validation studies.

Key Market Trends

The global viral clearance market is significantly influenced by the strategic shift towards integrating viral clearance assessments into the early stages of drug development. This proactive approach aims to identify and mitigate potential viral risks much sooner, ultimately streamlining the development timeline and reducing costly delays in later phases. Early consideration of viral clearance strategies also allows for the optimization of purification processes from the outset, ensuring regulatory compliance and product safety as a core component of the development paradigm rather than an afterthought. According to the Food and Drug Administration's Center for Drug Evaluation and Research, in June 2025, their "Analysis of Virus Clearance for Biotechnology Manufacturing Processes from Early to Late Phase Development" article highlighted that the risk for virus contamination in biotechnology products derived from mammalian cell lines must be evaluated from the early stages of development, underscoring this trend's regulatory and scientific importance.

Key Market Players

• Charles River Laboratories International, Inc.
• Wuxi Biologics Inc
• Eurofins Scientific SE
• Sartorius AG
• Texcell, Inc.
• Biosafety Testing Services, Inc.
• Avance Biosciences Laboratories Inc.

Report Scope:

In this report, the Global Viral Clearance Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Viral Clearance Market, By Application:

• Recombinant Proteins
• Blood
• Vaccines
• Others

Viral Clearance Market, By Method:

• Viral Removal Method
• Viral Inactivation Method
• Viral Detection Method

Viral Clearance Market, By End User:

• Pharmaceutical & Biotechnology Companies
• CROs
• Others

Viral Clearance Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Viral Clearance Market.

Available Customizations:

Global Viral Clearance Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Viral Clearance Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Recombinant Proteins, Blood, Vaccines, Others)
  • 5.2.2. By Method (Viral Removal Method, Viral Inactivation Method, Viral Detection Method)
  • 5.2.3. By End User (Pharmaceutical & Biotechnology Companies, CROs, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Viral Clearance Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Method
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Viral Clearance Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Method
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Viral Clearance Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Method
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Viral Clearance Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Method
      • 6.3.3.2.3. By End User

7. Europe Viral Clearance Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Method
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Viral Clearance Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Method
      • 7.3.1.2.3. By End User
  • 7.3.2. France Viral Clearance Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Method
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Viral Clearance Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Method
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Viral Clearance Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Method
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Viral Clearance Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Method
      • 7.3.5.2.3. By End User

8. Asia Pacific Viral Clearance Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Method
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Viral Clearance Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Method
      • 8.3.1.2.3. By End User
  • 8.3.2. India Viral Clearance Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Method
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Viral Clearance Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Method
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Viral Clearance Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Method
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Viral Clearance Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Method
      • 8.3.5.2.3. By End User

9. Middle East & Africa Viral Clearance Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Method
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Viral Clearance Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Method
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Viral Clearance Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Method
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Viral Clearance Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Method
      • 9.3.3.2.3. By End User

10. South America Viral Clearance Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Method
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Viral Clearance Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Method
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Viral Clearance Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Method
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Viral Clearance Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Method
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Viral Clearance Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Charles River Laboratories International, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Wuxi Biologics Inc
• 15.3. Eurofins Scientific SE
• 15.4. Sartorius AG
• 15.5. Texcell, Inc.
• 15.6. Biosafety Testing Services, Inc.
• 15.7. Avance Biosciences Laboratories Inc.

16. Strategic Recommendations

17. About Us & Disclaimer